代谢组学
疾病
阿尔茨海默病
代谢途径
痴呆
代谢组
蛋白质组学
神经科学
细胞外
医学
中枢神经系统
脂类学
生物
计算生物学
大鼠模型
代谢网络
氨基酸
神经退行性变
生物化学
脑脊液
代谢活性
脑化学
机制(生物学)
生物信息学
作者
Rayhanatou Altine Samey,Sylvie Mavel,Kelly Ceyzériat,Sylvie Chalon,Lydie Nadal‐Desbarats,Sylvie Bodard,Antoine Lefèvre,Julie Busson,Gabrielle Chicheri,Daniel Antier,Philippe Millet,Patrick Emond,Benjamin B. Tournier,Laura Foucault‐Fruchard
标识
DOI:10.1021/acs.jproteome.5c00047
摘要
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder, affecting millions of elderly patients and representing a common cause of dementia worldwide. Among the molecular and cellular processes involved in AD pathogenesis, the extracellular aggregation of β-amyloid (Aβ) has been strongly linked to AD progression. As AD advances, the metabolic profiles of the brain and other organs undergo significant changes. Metabolomics serves as an invaluable tool for discovering biomarkers to enable early diagnosis of AD. Using liquid chromatography-mass spectrometry (LC-MS), we analyzed brain tissues (from the frontal cortex and hippocampus), cerebrospinal fluid, and plasma from TgF344-AD rats (n = 8 males) and wild-type rats (n = 8), aged 7 months, identifying 710 analytically robust metabolites across the four biological matrices. A similar methodology was applied to 12 rats aged 22 months. Our results highlighted that the metabolomic profiles and altered metabolic pathways varied between early and advanced stages in both central and peripheral matrices. At 7 months, the metabolic fingerprint showed alterations predominantly affecting amino acid and lipid metabolism, whereas by 22 months, it shifted to a distinct fingerprint impacting amino acid, lipid, and nucleotide metabolism. These findings provide insights that could support the development of diagnostic tools and targeted therapeutic strategies tailored to each stage of the disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI